Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs
- PMID: 31752702
- PMCID: PMC6868749
- DOI: 10.1186/s12879-019-4606-y
Impact of co-existence of PMQR genes and QRDR mutations on fluoroquinolones resistance in Enterobacteriaceae strains isolated from community and hospital acquired UTIs
Abstract
Background: Fluoroquinolones are commonly recommended as treatment for urinary tract infections (UTIs). The development of resistance to these agents, particularly in gram-negative microorganisms complicates treatment of infections caused by these organisms. This study aimed to investigate antimicrobial resistance of different Enterobacteriaceae species isolated from hospital- acquired and community-acquired UTIs against fluoroquinolones and correlate its levels with the existing genetic mechanisms of resistance.
Methods: A total of 440 Enterobacteriaceae isolates recovered from UTIs were tested for antimicrobial susceptibility. Plasmid-mediated quinolone resistance (PMQR) genes and mutations in the quinolone resistance-determining regions (QRDRs) of gyrA and parC genes were examined in quinolone-resistant strains.
Results: About (32.5%) of isolates were resistant to quinolones and (20.5%) were resistant to fluoroquinolones. All isolates with high and intermediate resistance phenotypes harbored one or more PMQR genes. QnrB was the most frequent gene (62.9%) of resistant isolates. Co-carriage of 2 PMQR genes was detected in isolates (46.9%) with high resistance to ciprofloxacin (CIP) (MICs > 128 μg/mL), while co-carriage of 3 PMQR genes was detected in (6.3%) of resistant isolates (MICs > 512 μg/mL). Carriage of one gene only was detected in intermediate resistance isolates (MICs of CIP = 1.5-2 μg/mL). Neither qnrA nor qnrC genes were detected. The mutation at code 83 of gyrA was the most frequent followed by Ser80-Ile in parC gene, while Asp-87 Asn mutation of gyrA gene was the least, where it was detected only in high resistant E. coli isolates (MIC ≥128 μg/mL). A double mutation in gyrA (Lys154Arg and Ser171Ala) was observed in high FQs resistant isolates (MIC of CIP < 128 μg/mL).
Conclusion: FQs resistance is caused by interact between PMQR genes and mutations in both gyrA and parC genes while a mutation in one gene only can explain quinolone resistance. Accumulation of PMQR genes and QRDR mutations confers high resistance to FQs.
Keywords: Enterobacteriaceae; Fluoroquinolones; Plasmid-mediated quinolone resistance; Quinolone resistance-determining regions (QRDRs).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures
Similar articles
-
Co-existence of plasmid-mediated quinolone resistance determinants and mutations in gyrA and parC among fluoroquinolone-resistant clinical Enterobacteriaceae isolated in a tertiary hospital in Warsaw, Poland.Int J Antimicrob Agents. 2015 Mar;45(3):238-43. doi: 10.1016/j.ijantimicag.2014.09.019. Epub 2014 Nov 13. Int J Antimicrob Agents. 2015. PMID: 25468717
-
The determination of gyrA and parC mutations and the prevalence of plasmid-mediated quinolone resistance genes in carbapenem resistant Klebsiella pneumonia ST11 and ST76 strains isolated from patients in Heilongjiang Province, China.Infect Genet Evol. 2020 Aug;82:104319. doi: 10.1016/j.meegid.2020.104319. Epub 2020 Apr 8. Infect Genet Evol. 2020. PMID: 32278145
-
Characterization of quinolone resistance mechanisms in Enterobacteriaceae isolated from companion animals in Europe (ComPath II study).Vet Microbiol. 2018 Mar;216:159-167. doi: 10.1016/j.vetmic.2018.02.002. Epub 2018 Feb 11. Vet Microbiol. 2018. PMID: 29519511
-
Plasmid-mediated quinolone resistance: Mechanisms, detection, and epidemiology in the Arab countries.Infect Genet Evol. 2019 Dec;76:104020. doi: 10.1016/j.meegid.2019.104020. Epub 2019 Sep 4. Infect Genet Evol. 2019. PMID: 31493557 Review.
-
Molecular mechanisms associated with quinolone resistance in Enterobacteriaceae: review and update.Trans R Soc Trop Med Hyg. 2020 Oct 5;114(10):770-781. doi: 10.1093/trstmh/traa041. Trans R Soc Trop Med Hyg. 2020. PMID: 32609840 Review.
Cited by
-
Characterization of Transferrable Mechanisms of Quinolone Resistance (TMQR) among Quinolone-resistant Escherichia coli and Klebsiella pneumoniae causing Urinary Tract Infection in Nepalese Children.BMC Pediatr. 2023 Sep 13;23(1):458. doi: 10.1186/s12887-023-04279-5. BMC Pediatr. 2023. PMID: 37704964 Free PMC article.
-
Plasmid-mediated quinolone resistance genes detected in Ciprofloxacin non-susceptible Escherichia coli and Klebsiella isolated from children under five years at hospital discharge, Kenya.BMC Microbiol. 2023 May 13;23(1):129. doi: 10.1186/s12866-023-02849-2. BMC Microbiol. 2023. PMID: 37173674 Free PMC article.
-
Fluoroquinolone resistance among fecal extended spectrum βeta lactamases positive Enterobacterales isolates from children in Dar es Salaam, Tanzania.BMC Infect Dis. 2023 Mar 7;23(1):135. doi: 10.1186/s12879-023-08086-2. BMC Infect Dis. 2023. PMID: 36882712 Free PMC article.
-
Quinolone Resistance Genes and Their Contribution to Resistance in Vibrio cholerae Serogroup O139.Antibiotics (Basel). 2023 Feb 20;12(2):416. doi: 10.3390/antibiotics12020416. Antibiotics (Basel). 2023. PMID: 36830326 Free PMC article.
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention (CDC) Urinary Tract Infection (Catheter-Associated Urinary Tract Infection [CAUTI] and Non-Catheter-Associated Urinary Tract Infection [UTI]) and Other Urinary System Infection [USI] Events. 2018.
-
- Ponce-de-Leon A, Rodríguez-Noriega E, Morfín-Otero R, et al. Antimicrobial susceptibility of gram-negative bacilli isolated from intra-abdominal and urinary-tract infections in Mexico from 2009 to 2015: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) PLoS One. 2018;13(6):e0198621. doi: 10.1371/journal.pone.0198621. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
